0001203311-23-000116.txt : 20230922 0001203311-23-000116.hdr.sgml : 20230922 20230922194600 ACCESSION NUMBER: 0001203311-23-000116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230921 FILED AS OF DATE: 20230922 DATE AS OF CHANGE: 20230922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROMP CHARLES R CENTRAL INDEX KEY: 0001809717 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 231272802 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-09-21 0 0001060736 Seagen Inc. SGEN 0001809717 ROMP CHARLES R 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 EVP, Commercial U.S. 0 Common Stock 2023-09-21 4 S 0 45 206.5 D 69111 D The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/2/2021 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jennifer Prosba For: Charles R Romp 2023-09-22